WomenLift Health is hosting a live Q&A session with alumnae to discuss how participating in the India Leadership Journey has informed their personal and professional journeys. The session will provide insights on how the Journey enabled them to find their authentic leadership voice and navigate the barriers mid-career women face in public health in India.
This interactive session is an opportunity for prospective applicants to gain insights into the 2025 India Leadership Journey, ask questions, and explore how this fully funded, twelve-month leadership development experience, designed for mid-career women in health, can support their leadership growth
Register to Join the Session –>
Why Attend?
- Firsthand Alumnae Insights: Hear directly from WomenLift Health alumnae on how the program has elevated their leadership styles and approaches. It also offers a chance to ask alumnae and program leaders any questions about the leadership journey.
- Build Your Network: Uncover the power of supportive networks and mentorship for women’s career growth and explore networking opportunities.
- Learn What to Expect: Get all the information you need about the application process, programme structure, and more.
Who Can Attend?
All participants eligible to apply for the 2025 India Leadership Journey are invited to attend this live Q&A. Read more about our eligibility requirements →
Speakers
i. Madhura Kulkarni, Senior Scientist and DBT-Ramalingaswami Fellow, Prashanti Cancer Care Mission, Pune; WomenLift Health Leadership Journey Alumnae, India ‘22
ii. Mansharan Seth, Director, Clinton Health Access Initiative Inc. (CHAI); WomenLift Health Leadership Journey Alumna, India ‘23
iii. Pragyan Acharya, Additional Professor, All India Institute of Medical Sciences (AIIMS), New Delhi; WomenLift Health Leadership Journey Alumna, India ‘23
iv. Shubha Nagesh (Moderator), WomenLift Health Alumnae Lead, India
Already interested in applying? Learn more about the 2025 India Leadership Journey. We are currently accepting applications until October 25, 2024.